egfr mutant lung cancer: 2013 update
Published 5 years ago • 110 plays • Length 45:43Download video MP4
Download video MP3
Similar videos
-
45:43
egfr mutant lung cancer: 2013 update
-
45:43
egfr mutant lung cancer: 2013 update
-
3:38
overview of the world of egfr mutant lung cancers
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
47:45
resistance in braf and kras mutant cancers - by ryan corcoran, md, phd
-
3:31
ret as a target in lung cancer
-
2:10
chen-huang center for egfr mutant lung cancers | dana-farber cancer institute
-
20:07
acquired egfr resistance: what are the current therapeutic strategies?
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
3:02
osimertinib for treating non-small cell lung cancer
-
1:04
molecular testing in egfr mutant driven nsclc
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
17:45
individual treatments for individual egfr mutations
-
2:28
positive data announced for egfr-mutant nsclc
-
9:54
amivantamab combo with lazertinib favourable in post-osimertinib egfr-mutant nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
4:25
how to understand egfr t790m mutations | dana-farber cancer institute